Abiopharma

🔍 Treace John T. (Executive)

Company: TREACE MEDICAL CONCEPTS, INC. (TMCI)

Report Date: 2026-01-10

Detailed Transactions and Holdings:

• Sold 13,219 shares of Common Stock (Direct)
  Date: 2026-01-10 | Code: F | equity_swap_involved: false | shares_owned_after: 6,775,887.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-10 | Code: H | nature_of_ownership: By spouse | shares_owned_after: 1,605,000.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-10 | Code: H | nature_of_ownership: by spouse as trustee of a trust | shares_owned_after: 1,471,250.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-10 | Code: H | nature_of_ownership: As trustee of a trust | shares_owned_after: 1,839,063.00 | Footnotes: F3
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-10 | Code: H | nature_of_ownership: As co-trustee of a trust | shares_owned_after: 408,816.00 | Footnotes: F3

Footnotes:

• F1: Includes 363,867 restricted stock units.
• F2: The Reporting Person disclaims beneficial ownershup of shares held by his wife directly or in trusts for which his wife serves as trustee or co-trustee.
• F3: The Reporting Person disclaims beneficial ownership of shares held in trust for which he serves as trustee or co-trustee.